![Alan Hoberman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Hoberman
Direktor/Vorstandsmitglied bei
BIOXYTRAN, INC.
Vermögen: 13 150 $ am 31.08.2026
Profil
Dr. Alan M.
Hoberman is an Independent Director at BioXyTran, Inc. and a President & Chief Executive Officer at Argus International, Inc. He is on the Board of Directors at BioXyTran, Inc. Dr. Hoberman was previously employed as an Independent Director by Boston Therapeutics, Inc., an Executive Director-Site Operations & Toxicology by Argus Research Laboratories, Inc., and an Independent Director by Oxygen Therapy, Inc. He also served on the board at BioXyTran, Inc. /Old/.
He received his undergraduate degree from Drexel University, a graduate degree from The University of Arkansas and a doctorate degree from Pacific Western University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOXYTRAN, INC. 0.96% | 14.11.2025 | 416’207 ( 0.96% ) | 8 740 $ | 31.08.2026 |
BIOXYTRAN, INC. 0.18% | 18.11.2025 | 210’000 ( 0.18% ) | 4 410 $ | 31.08.2026 |
Aktive Positionen von Alan Hoberman
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOXYTRAN, INC. | Direktor/Vorstandsmitglied | 02.11.2018 |
Argus International, Inc.
 Argus International, Inc. Industrial MachineryProducer Manufacturing Manufactures and sells printed circuit boards and thin film coating equipment | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Alan Hoberman
| Unternehmen | Position | Ende |
|---|---|---|
Oxygen Therapy, Inc.
 Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-necrosis drugs | Direktor/Vorstandsmitglied | 03.08.2018 |
| NANOMIX CORPORATION | Direktor/Vorstandsmitglied | 15.09.2016 |
Argus Research Laboratories, Inc. | Corporate Officer/Principal | 01.01.2013 |
BioXyTran, Inc. /Old/
 BioXyTran, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Direktor/Vorstandsmitglied | - |
Ausbildung von Alan Hoberman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
13
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Arkansas
 The University of Arkansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pacific Western University
 Pacific Western University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Argus International, Inc.
Argus International, Inc. Industrial MachineryProducer Manufacturing Manufactures and sells printed circuit boards and thin film coating equipment | Producer Manufacturing |
Argus Research Laboratories, Inc. | |
Boston Therapeutics, Inc.
 Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and commercializes pharmaceutical products | Health Technology |
Oxygen Therapy, Inc.
Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-necrosis drugs | Health Technology |
BioXyTran, Inc. /Old/
BioXyTran, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
BioXyTran, Inc.
 BioXyTran, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that engages in the development, manufacture and commercialization of therapeutic drugs | Health Technology |
